Opendata, web and dolomites

GFeed

Safe and discrete gastrostomy tube for enteral feeding improving the delivery of nutrition and patient care.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GFeed project word cloud

Explore the words cloud of the GFeed project. It provides you a very rough idea of what is the project "GFeed" about.

tube    length    parts    rigid    fed    severe    population    chronic    delivers    trials    planning    shortcomings    bumper    gastroenterologist    swallow    ageing    reducing    hospitals    peg    patient    cleaner    animal    complication    patients    naturally    comfort    gastroenterology    discrete    pathologies    overcome    market    510    body    stoma    trauma    avoiding    replacement    healthcare    pharmacies    clinical    valued    feed    nutrition    safer    performed       decrease    accidental    small    weeks    distributed    hospital    internal    gastrostomy    validation    stay    solution    complies    port    million    placement    settings    reduce    departments    device    opening    dismantle    adoption    commercialization    complete    tubes    inside    dislodgment    intervention    insert    17    gain    initial    prevents    stomach    emergency    impairments    replaced    medications    care    semi    innovation    sold    kit    demand    disposable    feeding    free    clinics    human    expelled    unable    enteral    cagr    homecare    displacement    alternate    2015    time    hygienic    global    clogging    2020    feasibility    removal    driving    placed    gfeed    conceived   

Project "GFeed" data sheet

The following table provides information about the project.

Coordinator
FIDMI MEDICAL LTD 

Organization address
address: 17 TCHELET STREET
city: M.P Misgav
postcode: 2017400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.fidmimedical.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-12-01   to  2016-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FIDMI MEDICAL LTD IL (M.P Misgav) coordinator 50˙000.00

Map

 Project objective

Patients unable to swallow for long time due to severe pathologies are fed by gastrostomy tubes that deliver nutrition and medications directly into the stomach. GFeed provide a discrete solution for initial placement, replacement, and complete removal of enteral feeding device that overcome most of the shortcomings of currently used tubes. The semi-rigid internal bumper prevents accidental dislodgment and it is safer for the stoma opening. A disposable insert placed inside the feeding port delivers the nutrition into the stomach. This is replaced every 1-2 weeks, avoiding clogging and making the tube cleaner and more hygienic. The internal bumper is conceived to dismantle in small parts that are naturally expelled from the body for trauma free-removal. G-Feed complies with EU future challenge to face impairments due to ageing population and to reduce the length of hospital stay, that is driving the demand of enteral feeding devices in alternate care and homecare settings. The global market of PEG tubes, replacement tubes, and other gastrostomy tubes is valued $510 million in 2015 and growing at a CAGR of 5.5%. Over 17 million PEG tube procedures are expected in Europe and US by 2020. The initial placement kit is addressed to gastroenterology departments in hospitals and clinics, while the disposable insert is distributed to pharmacies and sold directly to the end-users, namely the enteral fed patients. GFeed adoption by gastroenterologist and their patients will enhance patient comfort and improve the delivery of nutrition by avoiding tube clogging, and will decrease healthcare cost by reducing the need for emergency intervention for displacement and/or complication. During phase 1, a feasibility study will be carried out, as well as the planning of clinical trials in chronic animal and human patient that will be performed during the whole innovation project, to gain the validation needed to bring the product to the commercialization.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GFEED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GFEED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

TT4CL (2019)

Clinical development of oral oleylphosphocholine as a new drug for the treatment of Old World Cutaneous Leishmaniasis

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More